Concepedia

Olga Vasilenko

OV

Statistics

Publications

6

Citations

690

H-Index

6

Active since

2009

Affiliations

National Institute of Allergy and Infectious Diseases(Current)

National Institutes of Health

Institute of Biochemistry and Physiology of Plants and Microorganisms

University of California San Diego

Olga Vasilenko is an author at National Institute of Allergy and Infectious Diseases specializing in medicine, immunology, and vaccination.

Top concepts

Publications per year

2009–2021

6

Publications

6

Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials

Martin R. Gaudinski, Katherine V. Houser, Kaitlyn M. Morabito et al. · The Lancet · 2017 · 298 citations · Full text

Safety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): an open-label phase 1 study

Martin R. Gaudinski, Emily E. Coates, Laura Novik et al. · The Lancet · 2019 · 123 citations · Full text

, , +10

Safety and pharmacokinetics of broadly neutralising human monoclonal antibody VRC07-523LS in healthy adults: a phase 1 dose-escalation clinical trial

Martin R. Gaudinski, Katherine V. Houser, Nicole A. Doria‐Rose et al. · The Lancet HIV · 2019 · 105 citations · Full text

, , +8

Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trial

Tracy J. Ruckwardt, Kaitlyn M. Morabito, Emily Phung et al. · The Lancet Respiratory Medicine · 2021 · 62 citations · Full text

, , +6

Immunostimulatory Effect of Gold Nanoparticles Conjugated with Transmissible Gastroenteritis Virus

Irina V. Vidyasheva, Olga Vasilenko, Lev A. Dykman · Bulletin of Experimental Biology and Medicine · 2011 · 54 citations · Full text

, , +7

1–5 of 6